Methacholine Challenge Testing - Identifying Its Diagnostic Role, Testing, Coding, And Reimbursement
airway; asthma; bronchial hyperresponsiveness; clinical-practice guidelines; coding; cough; function test; General & Internal Medicine; histamine; management; practice management; private practice; pulmonary; reimbursement; Respiratory System; responsiveness; sensitivity; smokers; spirometry
Birnbaum S; Barreiro T J
Chest
2007
2007-06
Journal Article or Conference Abstract Publication
<a href="http://doi.org/10.1378/chest.06-1385" target="_blank" rel="noreferrer noopener">10.1378/chest.06-1385</a>
Methacholine Challenge Testing - Identifying Its Diagnostic Role, Testing, Coding, And Reimbursement
airway; asthma; bronchial hyperresponsiveness; clinical-practice guidelines; coding; cough; function test; General & Internal Medicine; histamine; management; practice management; private practice; pulmonary; reimbursement; Respiratory System; responsiveness; sensitivity; smokers; spirometry
Methacholine challenge testing (MCT), also sometimes described as bronchoprovocation testing, is widely performed for both research and diagnostic purposes. MCT is clinically useful when the patient presents with a history of symptoms suggesting asthma, but spirometry findings are normal. Typically, MCT is performed in a pulmonary function laboratory, a clinic, or a physician's office. MCT requires time, effort, and understanding. Two standard testing regimes are identified along with proper coding and reimbursement methodologies.
Birnbaum S; Barreiro T J
Chest
2007
2007-06
Journal Article or Conference Abstract Publication
<a href="http://doi.org/10.1378/chest.06-1385" target="_blank" rel="noreferrer noopener">10.1378/chest.06-1385</a>
Hemodynamic Status During Famotidine Infusion
antagonist; depression; double-blind; h2-receptor; histamine; hypotension; intensive-care unit; intravenous cimetidine; Pharmacology & Pharmacy; ranitidine; secretion; ym-11170
Histamine H2 antagonists, which reduce gastric acid secretion, are often used in the intensive care setting for the prophylaxis of stress ulcers. This double-blind, placebo-controlled study evaluated hemodynamic parameters in 11 stable, critically ill patients receiving famotidine. Repeated-measures ANOVA demonstrated that famotidine had no significant effect on baseline hemodynamic measurements and that there was no significant difference in hemodynamic values following the famotidine infusion as compared with NaCl 0.9% placebo (p > 0.05).
Heiselman D E; Chapman J; Malik M; Riegnor E
Dicp-the Annals of Pharmacotherapy
1990
1990-12
Journal Article or Conference Abstract Publication
<a href="http://doi.org/10.1177/106002809002401202" target="_blank" rel="noreferrer noopener">10.1177/106002809002401202</a>